Johnson & Johnson orthopedic sales hit $9.3B in 2016 — 5 things to know

Spinal Tech

Johnson & Johnson's orthopedics business reported $2.3 billion sales in the fourth quarter of 2016 and $9.3 billion for the full year.

Here are five things to know:


1. In the fourth quarter, the U.S. orthopedics sales were $1.4 billion; international sales were $9.65 million. Worldwide sales dropped 1.5 percent to $2.3 billion. Full year sales grew 0.8 percent to $9.3 billion with U.S. sales reaching $5.5 billion and international sales hitting $3.8 billion.


2. U.S. hip sales reached $350 million in the fourth quarter and $1.3 billion for the full year. U.S. hip sales in the fourth quarter dropped 2.3 percent to $208 million, but full year sales in the U.S. grew 2.2 percent to $798 million.


3. Full year knee sales grew 1.9 percent to $1.5 billion, with U.S. sales hitting $943 million and international sales were $581 million. Fourth quarter knee sales dropped 2.5 percent to $395 million.


4. In the fourth quarter, trauma sales hit $654 worldwide, growing 4 percent to $394 million in the U.
S. Full year trauma sales were up 1.6 percent to $2.5 billion, with U.S. sales up 5.7 percent to $1.5 billion.


5. Spine and other sales slumped 3.1 percent in the fourth quarter, hitting $988 million. The full year spine and other sales were $3.8 billion, down 0.7 percent when compared with last year.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers